Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation

EMBO Journal

Volumn 16, Issue 18, 1997, Pages 5639-5653

  Quang, Christine Tran ^a   Wessely, Oliver ^b   Pironin, Martine ^a   Beug, Hartmut ^b   Ghysdael, Jacques ^a  

^a INSTITUT CURIE   (France)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

Apoptosis; c Kit; Erythropoietin receptor; Friend erythroleukemia; PU.1; Spi 1

Indexed keywords

CYTOKINE RECEPTOR; ERYTHROPOIETIN RECEPTOR; GLYCOPROTEIN; GROWTH FACTOR RECEPTOR; MUTANT PROTEIN; PROTEIN P53; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL CLONE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROLEUKEMIA; ETIOLOGY; FRIEND LEUKEMIA VIRUS; GENE MUTATION; GENE OVEREXPRESSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN FOCUS FORMING VIRUS; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; CHICKENS; ERYTHROBLASTS; ERYTHROPOIETIN; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MICE; PROTO-ONCOGENE PROTEINS; RECEPTORS, ERYTHROPOIETIN; RECOMBINANT PROTEINS; SPLEEN FOCUS-FORMING VIRUSES; STEM CELL FACTOR; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VIRAL ENVELOPE PROTEINS;

ANIMALIA; AVES; FRIEND MURINE LEUKEMIA VIRUS; MURINAE; SPLEEN FOCUS-FORMING VIRUS;

EID: 0030880189     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.18.5639     Document Type: Article

References (80)

1. Aizawa, S., Suda, Y., Furuta, Y., Yagi, T., Takeda, N., Watanabe, N., Nagayoshi, M. and Ikawa, Y. (1990) Env-derived gp55 gene of Friend spleen focus-forming virus specifically induces neoplastic proliferation of erythroid progenitor cells. EMBO J., 9, 2107-2116.
2. Ben-David, Y. and Bernstein, A. (1991) Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell, 66, 831-834.
3. Ben-David, Y., Lavigueur, A., Cheong, G. and Bernstein, A. (1990) Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes. New Biol., 2, 1015-1023.
4. Beug, H., Palmieri, S., Freudenstein, C., Zentgraf, H. and Graf, T. (1982) Hormone-dependent terminal differentiation in vitro of chicken erythroleukemia cells transformed by ts mutants of avian erythroblastosis virus. Cell, 28, 907-919.
5. Beug, H., Metz, T., Müllner, E.W. and Hayman, M. (1995a) Self renewal and differentiation in primary avian hematopoietic cells: An alternative to mammalian in vitro models? In Wolff, L. and Perkins, A. (eds), Molecular Aspects of Myeloid Stem Cell Development. Springer Verlag, New York and London, Vol. 213, pp. 29-42.
6. Beug, H., Schroeder, C., Wessely, O., Deiner, E., Meyer, S., Ischenko, I.D. and Hayman, M.J. (1995b) Transformation of erythroid progenitors by viral and cellular tyrosine kinases. Cell Growth Differ., 6, 999-1008.
7. Canman, C.E., Gilmer, T.M., Coutts, S.B. and Kastan, M.B. (1995) Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev., 9, 600-611.
8. Celada, A., Borras, F.E., Soler, C., Lloberas, J., Klemsz, M., van Beveren, C., McKercher, S. and Maki, R.A. (1996) The transcription factor PU.1 is involved in macrophage proliferation. J. Exp. Med., 184, 61-69.
9. Chow, V., Ben-David, Y., Bernstein, A., Benchimol, S. and Mowat, M. (1987) Multistage Friend erythroleukemia: independent origin of tumor clones with normal or rearranged p53 cellular oncogenes. J. Virol., 61, 2777-2781.
10. Crowe, A. and Hayman, M. (1991) A myristylated form of the sea oncoprotein can transform chicken embryo fibroblasts. J. Virol., 65, 2533-2538.
11. Delgado, M., Hallier, M., Meneceur, P. Tavitian, A. and Moreau-Gachelin, F. (1994) Inhibition of Friend cells proliferation by spi-1 antisense oligodeoxynucleotides.Oncogene, 9, 1723-1727.
12. Eisenbeis, C.F., Singh, H. and Storb, U. (1993) PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer. Mol. Cell Biol., 13, 6452-6461.
13. Elroy-Stein, O., Fuerst, T.R. and Moss, B. (1989) Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5′ sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proc. Natl Acad. Sci. USA, 86, 6126-6130.
14. Feinman, R., Qiu, W.Q., Pearse, R.N., Nikolajczyk, B.S., Sen, R., Sheffery, M. and Ravetch, J.V. (1994) PU.1 and an HLH family member contribute to the myeloid-specific transcription of the Fc gamma RIIIA promoter. EMBO J., 13, 3852-3860.
15. Gauthier, J., Bourachot, B., Doucas, V., Yaniv, M. and Moreau-Gachelin, F. (1993) Functional interference between the Spi-1/PU.1 oncoprotein and steroid hormone or vitamin receptors. EMBO J., 12, 5089-5096.
16. Ghysdael, J. and Boureux, A. (1997) The Ets family of transcriptional regulators. In Yaniv, M. and Ghysdael, J. (eds), Oncogenes as Transcriptional Regulators. Birkhauser Verlag, Basel, Vol. 1, pp. 29-89.
17. Glineur, C., Zenke, M., Beug, H. and Ghysdael, J. (1990) Phosphorylation of the v-erbA protein is required for its function as an oncogene. Genes Dev., 4, 1663-1676.
18. Gorzyca, W., Gong, J. and Darzynkiewics, Z. (1993) Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl-transferase and nick translation assays. Cancer Res., 53, 1945-1951.
19. Gottlieb, E., Haffner, R., von Ruden, T., Wagner, E. and Oren, M. (1994) Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J., 13, 1368-1374.
20. Gregory, C. and Eaves, A. (1978) Three stages of erythropoietic progenitor cells differentiation distinguished by a number of physical and biologic properties. Blood, 51, 527-536.
21. Hagemeier, C., Bannister, A.J., Cook, A. and Kouzarides, T. (1993) The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc. Natl Acad. Sci. USA, 90, 1580-1584.
22. Hankins, W. (1980) Polycythemia- and anemia-inducing erythroleukemia viruses exhibit differential erythroid transforming effects in vitro. Cell, 22, 693-699.
23. Hankins, W.D., Krantz, S.B., Kost, T.A. and Koury, M.J. (1980) In vitro transformation of mouse hematopoietic cells by the spleen focus-forming virus. Cold Spring Harbor Symp. Quant. Biol., 44, 1211-1214.
24. Hayman, M. Meyer, S., Martin, F., Steinlein, P. and Beug, H. (1993) Self-renewal and differentiation of normal avian erythroid progenitor cells: regulatory roles of the TGF alpha/c-ErbB and SCF/c-kit receptors. Cell, 74, 157-169.
25. Hoatlin, M., Kozak, S., Lilly, F., Chakraborti, A., Kozak, C. and Kabat, D. (1990) Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene. Proc. Natl Acad. Sci. USA, 87, 9985-9989.
26. Hughes, S.H., Greenhouse, J.J., Petropoulos, C.J. and Sutrave, P. (1987) Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J. Virol., 61, 3004-3012.
27. Ihle, J.N. (1995) Cytokine receptor signalling. Nature, 377, 591-594.
28. Johnson, P. and Benchimol, S. (1992) Friend virus induced murine erythroleukaemia: the p53 locus. Cancer. Surv., 12, 137-151.
29. Johnson, P., Chung, S. and Benchimol, S. (1993) Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol. Cell Biol., 13, 1456-1463.
30. Kabat, D. (1989) Molecular biology of Friend viral erythroleukemia. Curr. Top. Microbiol. Immunol., 148, 1-42.
31. Kahn, P., Frykberg, L., Brady, C., Stanley, I., Beug, H., Vennstrom, B. and Graf, T. (1986) v-erbA cooperates with sarcoma oncogenes in leukemic cell transformation. Cell, 45, 349-356.
32. Khazaie, K., Dull, T., Graf, T., Schlessinger, J., Ullrich, A., Beug, H. and Vennstrom, B. (1988) Truncation of the human EGF receptor leads to differential transforming potentials in primary avian fibroblasts and erythroblasts. EMBO J., 7, 3061-3071.
33. Klemsz, M. and Maki, R. (1996) Activation of transcription by Pu-1 requires both acidic and glutamine domains. Mol. Cell Biol., 16, 390-397.
34. Klemsz, M., McKercher, S., Celada, A., Van Beveren, C. and Maki, R. (1990) The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell, 61, 113-124.
35. Knight, J., Zenke, M., Disela, C., Kowenz, E., Vogt, P., Engel, J., Hayman, M. and Beug, H. (1988) Temperature-sensitive v-sea transformed erythroblasts: a model system to study gene expression during erythroid differentiation. Genes Dev., 2, 247-258.
36. Kodandapani, R., Pio, F., Ni, C.Z., Piccialli, G., Klemsz, M., McKercher, S., Maki, R.A. and Ely, K.R. (1996) A new pattern for helix-turn-helix recognition revealed by the PU.1 ETS-domain-DNA complex. Nature, 380, 456-460.
37. Koury, M. and Bondurant, M. (1992) The molecular mechanism of erythropoietin action. Eur. J. Biochem, 210, 649-663.
38. Koury, M.J., Sawyer, S.T. and Bondurant, M.C. (1984) Splenic erythroblasts in anemia-inducing Friend disease: a source of cells for studies of erythropoietin-mediated differentiation. J. Cell. Physiol., 121, 526-532.
39. Kowenz, E., Leutz, A., Doderlein, G., Graf, T. and Beug, H. (1987) ts-oncogene-transformed erythroleukemic cells: a novel test system for purifying and characterizing avian erythroid growth factors. Haematol. Bluttransfus., 31, 199-209.
40. Levine, A.J., Momand, J. and Finlay, C.A. (1991) The p53 tumour suppressor gene. Nature, 351, 453-456.
41. Li, J. and Baltimore, D. (1991) Mechanism of leukemogenesis induced by mink cell focus-forming murine leukemia viruses. J. Virol., 2408-2414.
42. Lodie, T., Savedra, R., Golenbock, D., Van Beveren, C., Maki, R. and Fenton, M. (1997) Stimulation of macrophages by lipopolysaccharide alters the phosphorylation stages, conformation, and function of Pu.1 via activation of casein kinase II. J. Immunol., 158, 1848-1856.
43. Longmore, G.D. and Lodish, H.F. (1991) An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: a cytokine receptor superfamily oncogene. Cell, 67, 1089-1102.
44. Lotem, J. and Sachs, L. (1993) Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood, 82, 1092-1096.
45. Mager, D., Mak, A. and Bernstein, A. (1981) Quantitative colony method for tumorigenic cells transformed by two distinct strains of Friend leukemia virus. Proc. Natl Acad. Sci. USA, 78, 1703-1707.
46. Mayeux, P., Casadevall, N., Muller, O. and Lacombe, C. (1990) Glycosylation of the murine erythropoietin receptor. FEBS Lett., 269, 167-170.
47. McKercher, S.R. et al. (1996) Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J., 15, 5647-5658.
48. Miura, O., Miura, Y., Nakamura, N., Quelle, F.W., Witthuhn, B.A., Ihle, J.N. and Aoki, N. (1994) Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood, 84, 4135-4141.
49. Moreau-Gachelin, F., Tavitian, A. and Tambourin, P. (1988) Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature, 331, 277-280.
50. Moreau-Gachelin, F., Wendling, F., Molina, T., Denis, N., Titeux, M., Grimber, G., Briand, P. Vainchenker, W. and Tavitian, A. (1996) Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol. Cell Biol., 16, 2453-2463.
51. Mowat, M., Cheng, A., Kimura, N., Bernstein, A. and Benchimol, S. (1985) Rearrangement of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus. Nature, 314, 633-636.
52. Munroe, D., Peacock, J. and Benchimol, S. (1990) Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles. Mol. Cell Biol., 10, 3307-3313.
53. Muta, K. and Krantz, S.B. (1993) Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J. Cell. Physiol., 156, 264-271.
54. Nagulapalli, S., Pongubala, J.M. and Atchison, M.L. (1995) Multiple proteins physically interact with PU.1. Transcriptional synergy with NF-IL6 beta (C/EBP delta, CRP3). J. Immunol., 155, 4330-4338.
55. Nocka, K., Majumder, S., Chabot, B., Ray, P., Cervone, M., Bernstein, A. and Besmer, P. (1989) Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice -evidence for an impaired c-kit kinase in mutant mice. Genes Dev., 3, 816-826.
56. Nocka, K., Buck, J., Levi, E. and Besmer, P. (1990) Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. EMBO J., 9, 3287-3294.
57. Ohashi, T., Masuda, M. and Ruscetti, S.K. (1995) Induction of sequence-specific DNA-binding factors by erythropoietin and the spleen focus-forming virus. Blood, 85, 1454-1462.
58. Pain, B. et al. (1991) EGF-R as a hemopoietic growth factor receptor: the c-erbB product is present in chicken crythrocytic progenitors and controls their self-renewal. Cell, 65, 37-46.
59. Paul, R., Schuetze, S., Kozak, S., Kozak, C. and Kabat, D. (1991) The Sfpi-1. proviral integration site of Friend erythroleukemia encodes the ets-related transcription factor Pu.1. J. Virol., 65, 464-467.
60. Pharr, P.N., Hankins, D., Hofbauer, A., Lodish, H.F. and Longmore, G.D. (1993) Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth. Proc. Natl Acad. Sci. USA, 90, 938-942.
61. Pongubala, J.M., Nagulapalli, S., Klemsz, M.J., McKercher, S.R., Maki, R.A. and Atchison, M.L. (1992) PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3′ enhancer activity. Mol. Cell Biol., 12, 368-378.
62. Pongubala, J., Van Beveren, C. Nagulapalli, S., Klemsz, M., McKercher, S., Maki, R. and Atchison, M. (1993) Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science, 259, 1622-1625.
63. Ruscetti, S.K., Janesch, N.J., Chakraborti, A., Sawyer, S.T. and Hankins, W.D. (1990) Friend spleen focus-forming virus induces factor independence in an erythropoietin-dependent erythroleukemia cell line. J. Virol., 64, 1057-1062.
64. Schroeder, C., Gibson, L., Zenke, M. and Beug, H. (1992) Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action. Oncogene, 7, 217-227.
65. Schuetze, S., Stenberg, P. and Kabat, D. (1993) The Ets-related transcription factor PU.1 immortalizes erythroblasts. Mol. Cell Biol., 13, 5670-5678.
66. Scott, E.W., Simon, M.C., Anastasi, J. and Singh, H. (1994) Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science, 265, 1573-1577.
67. Shikama, Y. Barber, D.L., D'Andrea, A.D. and Sieff, C.A. (1996) A constitutively activated chimeric cytokine receptor confers factor-independent growth in hematopoietic cell lines. Blood, 88, 455-464.
68. Shin, M.K. and Koshland, M.E. (1993) Ets-related protein PU.1 regulates expression of the immunoglobulin J-chain gene through a novel Ets-binding element. Genes Dev., 7, 2006-2015.
69. Silva, M., Grillot, D., Benito, A., Richard, C., Nunez, G. and Fernandez-Luna, J.L. (1996) Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood, 88, 1576-1582.
70. Steinlein, P., Deiner, E., Leutz, A. and Beug, H. (1994) Recombinant murine erythropoietin receptor expressed in avian erythroid progenitors mediates terminal erythroid differentiation in vitro. Growth Factors, 10, 1-16.
71. Teich, N., Wyke, J., Mak, T., Bernstein, A. and Hardy, W. (1982) Pathogenesis of retrovirus-induced disease. In RNA Tumor Viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 785-998.
72. Tran Quang, C., Pironin, M. Von Lindern, M., Beug, H. and Ghysdael, J. (1995) Spi-1 and mutant p53 regulate different aspects of the proliferation and differentiation of primary erythroid progenitors. Oncogene, 11, 1229-1239.
73. Ulrich, E., Boehmelt, G., Bird, A. and Beug, H. (1992) Immortalization of conditionally transformed chicken cells: loss of normal p53 expression is an early step that is independent of cell transformation. Genes Dev, 6, 876-887.
74. Weintraub, S.J., Chow, K.N., Luo, R.X., Zhang, S.H., He, S. and Dean, D.C. (1995) Mechanism of active transcriptional repression by the retinoblastoma protein. Nature, 375, 812-815.
75. Wessely, O., Deiner, E., Beug, H. and Von Lindern, M. (1997a) The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors. EMBO J., 16, 267-280.
76. Wessely, O., Von Lindern, M., Levitzki, A., Gazit, A., Ischenko, I., Mellitzer, G., Hayman, M. and Beug, H. (1997b) Distinct regulatory roles of the receptor tyrosine kinases c-erbB and c-Kit in erythroid differentiation and proliferation. Cell Growth. Differ., 8, 481-493.
77. Wolff, L. and Ruscetti, S. (1988) The spleen focus-forming virus (SFFV) envelope gene, when introduced into mice in the absence of other SFFV genes, induces acute erythroleukemia. J. Virol., 62, 2158-2163.
78. Yoshimura, A., Longmore, G. and Lodish, H.F. (1990) Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature, 348, 647-649.
79. Zenke, M. et al. (1988) v-erbA specifically suppresses transcription of the avian erythrocyte anion transporter (band 3) gene. Cell, 52, 107-119.
80. Zenke, M., Munoz, A., Sap, J., Vennstrom, B. and Beug, H. (1990) v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell, 61, 1035-1049.